Patented polymer delivery system specialist Skinvisible, Inc. has joined with pharmaceuticals provider Cambrex Corporation in a marketing and development agreement.

According to Skinvisible, the plan provides for research and development into acne formulations based on Skinvisible's Invisicare technology and benzoyl peroxide manufactured by Cambrex.

In addition, the two companies will share marketing responsibilities for the products that are developed under this agreement.